These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 19664724)

  • 1. Histone deacetylase inhibitor uses p21(Cip1) to maintain anergy in CD4+ T cells.
    Dagtas AS; Edens RE; Gilbert KM
    Int Immunopharmacol; 2009 Oct; 9(11):1289-97. PubMed ID: 19664724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p21(Cip1) up-regulated during histone deacetylase inhibitor-induced CD4(+) T-cell anergy selectively associates with mitogen-activated protein kinases.
    Selma Dagtas A; Gilbert KM
    Immunology; 2010 Apr; 129(4):589-99. PubMed ID: 20102411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p21Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells.
    Rocchi P; Tonelli R; Camerin C; Purgato S; Fronza R; Bianucci F; Guerra F; Pession A; Ferreri AM
    Oncol Rep; 2005 Jun; 13(6):1139-44. PubMed ID: 15870934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone deacetylase inhibitors induce antigen specific anergy in lymphocytes: a comparative study.
    Edens RE; Dagtas S; Gilbert KM
    Int Immunopharmacol; 2006 Nov; 6(11):1673-81. PubMed ID: 16979121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. n-Butyrate anergized effector CD4+ T cells independent of regulatory T cell generation or activity.
    Fontenelle B; Gilbert KM
    Scand J Immunol; 2012 Nov; 76(5):457-63. PubMed ID: 22724664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of anergy in Th1 cells associated with increased levels of cyclin-dependent kinase inhibitors p21Cip1 and p27Kip1.
    Jackson SK; DeLoose A; Gilbert KM
    J Immunol; 2001 Jan; 166(2):952-8. PubMed ID: 11145672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter.
    Yokota T; Matsuzaki Y; Miyazawa K; Zindy F; Roussel MF; Sakai T
    Oncogene; 2004 Jul; 23(31):5340-9. PubMed ID: 15107822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scriptaid and suberoylanilide hydroxamic acid are histone deacetylase inhibitors with potent anti-Toxoplasma gondii activity in vitro.
    Strobl JS; Cassell M; Mitchell SM; Reilly CM; Lindsay DS
    J Parasitol; 2007 Jun; 93(3):694-700. PubMed ID: 17626366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic induction of oxidative injury and apoptosis in human multiple myeloma cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitors.
    Pei XY; Dai Y; Grant S
    Clin Cancer Res; 2004 Jun; 10(11):3839-52. PubMed ID: 15173093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence of a functional role for p21WAF1/CIP1 down-regulation in synergistic antileukemic interactions between the histone deacetylase inhibitor sodium butyrate and flavopiridol.
    Rosato RR; Almenara JA; Yu C; Grant S
    Mol Pharmacol; 2004 Mar; 65(3):571-81. PubMed ID: 14978235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Regulation of histone acetylation on the expression of cell cycle-associated genes in human colon cancer cell lines].
    Chen YX; Fang JY; Lu J; Qiu DK
    Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):312-7. PubMed ID: 15059516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone deacetylase inhibitor, Trichostatin A, activates p21WAF1/CIP1 expression through downregulation of c-myc and release of the repression of c-myc from the promoter in human cervical cancer cells.
    Li H; Wu X
    Biochem Biophys Res Commun; 2004 Nov; 324(2):860-7. PubMed ID: 15474507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationship between carboxylic acids and T cell cycle blockade.
    Gilbert KM; DeLoose A; Valentine JL; Fifer EK
    Life Sci; 2006 Apr; 78(19):2159-65. PubMed ID: 16318858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone deacetylase inhibitors reduce VEGF production and induce growth suppression and apoptosis in human mantle cell lymphoma.
    Heider U; Kaiser M; Sterz J; Zavrski I; Jakob C; Fleissner C; Eucker J; Possinger K; Sezer O
    Eur J Haematol; 2006 Jan; 76(1):42-50. PubMed ID: 16343270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The histone deacetylase inhibitor butyrate downregulates cyclin B1 gene expression via a p21/WAF-1-dependent mechanism in human colon cancer cells.
    Archer SY; Johnson J; Kim HJ; Ma Q; Mou H; Daesety V; Meng S; Hodin RA
    Am J Physiol Gastrointest Liver Physiol; 2005 Oct; 289(4):G696-703. PubMed ID: 16160080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of the cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa Cells.
    Liu PY; Chan JY; Lin HC; Wang SL; Liu ST; Ho CL; Chang LC; Huang SM
    Mol Cancer Res; 2008 Jul; 6(7):1204-14. PubMed ID: 18644983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carboxypeptidase A3 (CPA3): a novel gene highly induced by histone deacetylase inhibitors during differentiation of prostate epithelial cancer cells.
    Huang H; Reed CP; Zhang JS; Shridhar V; Wang L; Smith DI
    Cancer Res; 1999 Jun; 59(12):2981-8. PubMed ID: 10383164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone deacetylase inhibitor suppression of autoantibody-mediated arthritis in mice via regulation of p16INK4a and p21(WAF1/Cip1) expression.
    Nishida K; Komiyama T; Miyazawa S; Shen ZN; Furumatsu T; Doi H; Yoshida A; Yamana J; Yamamura M; Ninomiya Y; Inoue H; Asahara H
    Arthritis Rheum; 2004 Oct; 50(10):3365-76. PubMed ID: 15476220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Keratin 23 (K23), a novel acidic keratin, is highly induced by histone deacetylase inhibitors during differentiation of pancreatic cancer cells.
    Zhang JS; Wang L; Huang H; Nelson M; Smith DI
    Genes Chromosomes Cancer; 2001 Feb; 30(2):123-35. PubMed ID: 11135429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential clinical use of butyric acid derivatives to induce antigen-specific T cell inactivation.
    Gilbert KM; Wahid R; Fecher NP; Freeman JP; Fifer EK
    J Pharmacol Exp Ther; 2000 Sep; 294(3):1146-53. PubMed ID: 10945871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.